ONO-4053 Phase 2a study

ONO-4053 Phase 2a study A multicenter, double-blind, randomized parallel-group study in patients with seasonal allergic rhinitis.

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222655

Enrollment

200

Registered

2014-11-13

Start date

2014-11-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

seasonal allergic rhinitis (Japanese cedar pollinosis)

Interventions

investigational material(s) Generic name etc : ONO-4053 INN of investigational material : Therapeutic category code : 449 Other antiallergic agents Dosage and Administration for Investigational mater

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. patients with seasonal allergic rhinitis (Japanese cedar pollinosis)

Exclusion criteria

Exclusion criteria: 1. Has a disease which may influence the efficacy evaluation (e.g. acute rhinitis) 2. Has or had a history of an allergic drug reaction 3. If female, are pregnant or breastfeeding

Design outcomes

Primary

Measure	Time frame
nasal symptom score	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026